文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

右美托咪定对脓毒症合并急性呼吸窘迫综合征患者肺的保护作用及机制

[Effect and mechanism of dexmedetomidine on lungs in patients of sepsis complicated with acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论在脓毒症合并ARDS成人机械通气患者中,右美托咪定较丙泊酚更显著降低血清IL-6、TNF-α及肺泡细胞TLR4、MyD88、p-JNK表达并升高p-Akt。

该研究纳入脓毒症合并ARDS成人患者,氧合指数150-200 mmHg、APACHE II评分10-20、需机械通气>72小时,随机分为无镇静组、丙泊酚组(0.3-4.0 mg×kg-1×h-1)和右美托咪定组(0.2-0.7 μg×kg-1×h-1),三组均以瑞芬太尼充分镇痛,镇静目标RASS -1至0。结果显示无镇静组血清炎症因子及肺泡脱落细胞炎症信号蛋白、抗凋亡信号蛋白无显著变化;丙泊酚组和右美托咪定组镇静后血清IL-6、TNF-α及肺泡细胞TLR4、MyD88、p-JNK表达均显著降低,且右美托咪定组较丙泊酚组降低更显著(如72小时TLR4 IA值0.288±0.034 vs. 0.648±0.029,P<0.05);两组p-Akt表达均显著升高,右美托咪定组较丙泊酚组升高更显著(IA值1.032±0.030 vs. 0.743±0.028,P<0.05)。作者结论认为右美托咪定通过TLR4-MyD88-JNK信号通路对脓毒症合并ARDS患者肺发挥保护作用。

要点

  • 右美托咪定组较丙泊酚组在镇静72小时血清IL-6(ng/L)为272.18±42.76 vs. 304.49±44.93,TNF-α为102.18±30.25 vs. 140.28±28.92,均P<0.05。
  • 右美托咪定组较丙泊酚组在镇静72小时肺泡细胞TLR4(IA值)0.288±0.034 vs. 0.648±0.029、MyD88 0.356±0.030 vs. 0.752±0.044、p-JNK 0.256±0.027 vs. 0.303±0.034,均P<0.05。
  • 右美托咪定组较丙泊酚组肺泡细胞p-Akt表达(IA值)升高更显著:1.032±0.030 vs. 0.743±0.028,P<0.05。
  • 无镇静组血清炎症因子及肺泡脱落细胞炎症信号蛋白、抗凋亡信号蛋白均无显著变化。
  • 作者结论认为右美托咪定通过TLR4-MyD88-JNK信号通路对脓毒症合并ARDS患者肺发挥保护作用。

适用人群与场景

  • 成人脓毒症合并ARDS患者,氧合指数(PaO2/FiO2)150-200 mmHg(1 mmHg=0.133 kPa),APACHE II评分10-20,需机械通气治疗>72小时,收入广西医科大学第一附属医院重症医学科(ICU),时间2013年9月至2017年6月。

诊断标准与关键阈值

  • 镇静目标为Richmond躁动-镇静评分(RASS)-1至0。

处置流程与药物剂量

  • 三组均以瑞芬太尼充分镇痛。
  • 丙泊酚组给予丙泊酚0.3-4.0 mg×kg-1×h-1。
  • 右美托咪定组给予右美托咪定0.2-0.7 μg×kg-1×h-1。
  • 无镇静组未给予镇静药物。

研究设计与关键结果

  • 研究为随机对照研究,纳入脓毒症合并ARDS成人患者,随机分为无镇静组、丙泊酚组和右美托咪定组(每组n=80)。
  • 无镇静组血清炎症因子及肺泡脱落细胞炎症信号蛋白、抗凋亡信号蛋白无显著变化。
  • 丙泊酚组和右美托咪定组镇静后血清IL-6、TNF-α及肺泡细胞TLR4、MyD88、p-JNK表达均显著降低,且右美托咪定组较丙泊酚组降低更显著:48小时TNF-α(ng/L)153.76±29.16 vs. 179.82±30.28;72小时IL-6(ng/L)272.18±42.76 vs. 304.49±44.93,TNF-α(ng/L)102.18±30.25 vs. 140.28±28.92,TLR4(IA值)0.288±0.034 vs. 0.648±0.029,MyD88(IA值)0.356±0.030 vs. 0.752±0.044,p-JNK(IA值)0.256±0.027 vs. 0.303±0.034,均P<0.05。
  • 丙泊酚组和右美托咪定组肺泡细胞p-Akt表达均显著升高,且右美托咪定组较丙泊酚组升高更显著(IA值:1.032±0.030 vs. 0.743±0.028,P<0.05)。

证据类型、等级与局限

  • 证据类型:随机对照研究(原文按随机数字表法分组)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为右美托咪定通过TLR4-MyD88-JNK信号通路对脓毒症合并ARDS患者肺发挥保护作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the mechanisms of protective effects of dexmedetomidine on lungs in patients of sepsis complicated with acute respiratory distress syndrome (ARDS).

METHODS: The adult patients with sepsis complicated with ARDS, the oxygenation index (PaO2/FiO2) was 150-200 mmHg (1 mmHg = 0.133 kPa), acute physiology and chronic health evaluation II (APACHE II) score was 10-20, need mechanical ventilation (MV) treatment > 72 hours, and admitted to intensive care unit (ICU) of the First Affiliated Hospital of Guangxi Medical University from September 2013 to June 2017 were enrolled. According to the random number table method, the patients were divided into three groups (n = 80): no sedation group, propofol group (0.3-4.0 mg×kg-1×h-1) and dexmedetomidine group (0.2-0.7 μg×kg-1×h-1). The three groups were adequately analgesic treated with remifentanil. The sedation target was -1-0 of Richmond agitation-sedation score (RASS). The levels of interlenkin-6 (IL-6) and tumor necrosis factor-α (INF-α) were determined by enzyme linked immunosorbent assay (ELISA) before sedation, and 24, 48, 72 hours after sedation. The expressions of inflammatory signaling proteins in bronchoalveolar lavage fluid (BALF) were determined by Western Blot before sedation and 72 hours after sedation.

RESULTS: There were no significant changes for inflammatory factors in serum, and inflammatory signaling proteins and anti-apoptotic signaling proteins in alveolar exfoliated cells in no sedation group. The levels of IL-6 and TNF-α in serum and the expressions of Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88) and phosphorylated c-Jun N-terminal kinase (p-JNK) in alveolar cells in propofol group and dexmedetomidine group were all significantly reduced after sedation, moreover, it was more significantly in the dexmedetomidine group compared with propofol group [48 hours: TNF-α (ng/L) was 153.76±29.16 vs. 179.82±30.28; 72 hours: IL-6 (ng/L) was 272.18±42.76 vs. 304.49±44.93, TNF-α (ng/L) was 102.18±30.25 vs. 140.28±28.92, TLR4 (IA value) was 0.288±0.034 vs. 0.648±0.029, MyD88 (IA value): 0.356±0.030 vs. 0.752±0.044, p-JNK (IA value): 0.256±0.027 vs. 0.303±0.034, all P < 0.05]. The expression of p-Akt in alveolar cells in propofol group and dexmedetomidine group was all significant increased after sedation, moreover, it was more significantly in the dexmedetomidine group compared with propofol group (IA value: 1.032±0.030 vs. 0.743±0.028, P < 0.05).

CONCLUSIONS: Dexmedetomidine exerts the protective effects on lungs in patients of sepsis complicated with ARDS through the TLR4-MyD88-JNK signaling pathway.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen X, Hu J, Zhang C, et al. [Effect and mechanism of dexmedetomidine on lungs in patients of sepsis complicated with acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29402365. doi:10.3760/cma.j.issn.2095-4352.2018.02.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。